The cannabinoid agonist market is gaining momentum due to expanding medical cannabis legalization and growing clinical validation for its use in chronic pain, epilepsy, and inflammatory conditions.

You might have heard cannabis and cannabinoid products can help people sleep. Data shows one of the top reasons people use ...

Ophthalmology Times connects eye care professionals with surgery, imaging, gene therapy, & diagnostic advances to enhance ...

But overall, our findings suggest cannabinoids may acutely influence sleep, primarily by suppressing REM sleep, without ...

As patients increasingly turn to cannabis for chronic pain, clinicians grapple with mixed evidence and a lack of high-quality ...

Exhale Wellness officially announced two new strains in its THCA flower collection for 2025 - Skywalker OG and Sunset Sherbet. Read more details.

Exhale Wellness launches its new line of Delta 9 Gummies - Bottle Caps. Learn about the product - ingredients, flavors, lab ...

Skye’s Nimacimab shows promise in obesity treatment with lean mass preservation. Phase 2a results slated for 2025 could drive ...

A study published in Neuroscience Letters finds that cannabidiol (CBD) and cannabichromene (CBC) can significantly reverse the effects of chronic sleep deprivation (cSD), which include memory ...

The study found that youth who vaped cannabis experienced more mental-health symptoms than those who smoked dry herbs and ...

Teen vaping habits are shifting toward stronger and more mysterious substances. Synthetic cannabinoids are rising fast — and ...